Cushing syndrome

DOID EFO MESH SNOMED Endpoint Browser PheWeb

E4_CUSHING

hyperaldosteronism: Overproduction of aldosterone by the adrenal glands, which may lead to hypokalemia and/or hypernatremia. [ NCIT:P378 ]

Endpoint definition

↥

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 E24

Hospital discharge: ICD-9 2550|2593

Hospital discharge: ICD-8 2580

Cause of death: ICD-10 E24

Cause of death: ICD-9 2550|2593

Cause of death: ICD-8 2580

2 out of 7 registries used, show all original rules.

337

diagram downward connector

Check minimum number of events None

337

diagram downward connector

Include endpoints None

337

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

326

diagram downward connector

E4_CUSHING

Control definitions

Control exclude E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF6

Parent code in ICD-10 E20-E35

Name in latin Syndroma Cushing

NAME	E4_CUSHING
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E24
HD_ICD_9	2550\|2593
HD_ICD_8	2580
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E24
COD_ICD_9	2550\|2593
COD_ICD_8	2580
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Cushing syndrome based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	326	229	97
Unadjusted prevalence (%)	0.08	0.10	0.05
Mean age at first event (years)	47.25	45.20	52.07

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_CUSHING – Cushing syndrome
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Cushing syndrome
after Cushing syndrome

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Cushing syndrome

↥

Endpoint not on priority list, no data to show.